Bausch & Lomb (BLCO) Intangibles (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Intangibles came in at $3.2 billion in Q2 2026, down 5.71% on a YoY basis from $3.4 billion in Q2 2025, and down 1.77% quarter-over-quarter from $3.2 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Intangibles (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Intangibles for 6 consecutive years, with $3.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Intangibles fell 5.71% year-over-year to $3.2 billion; the trailing twelve-month figure through Jun 2026 stood at $3.2 billion (down 5.71% YoY), and the FY2025 full-year result was $3.3 billion, down 6.1% from the prior year.
- Intangibles retreated to $3.2 billion in Q2 2026 per BLCO's latest filing, from $3.2 billion in the prior quarter.
- Across five years, Intangibles topped out at $3.7 billion in Q3 2023 and bottomed at $2.0 billion in Q2 2023.
- Historically, Intangibles has averaged $3.0 billion across 5 years, with a median of $3.3 billion in 2025.
- The sharpest annual moves came in 2022 and 2023: Intangibles decreased 9.1% in 2022, then surged 77.08% in 2023.
- Over 5 years, Intangibles stood at $2.1 billion in 2022, then soared by 74.39% to $3.6 billion in 2023, then retreated by 2.65% to $3.5 billion in 2024, then slipped by 6.1% to $3.3 billion in 2025, then decreased by 3.41% to $3.2 billion in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $3.2 billion, $3.2 billion, and $3.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.21 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.14 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 10.24 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 5.74 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.92 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.38 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 8.27 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 101.60 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.56 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 3.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Bn |
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.28 Bn |
| Sep 30, 2025 | 3.33 Bn |
| Jun 30, 2025 | 3.36 Bn |
| Mar 31, 2025 | 3.43 Bn |
| Dec 31, 2024 | 3.49 Bn |
| Sep 30, 2024 | 3.38 Bn |
| Jun 30, 2024 | 3.44 Bn |
| Mar 31, 2024 | 3.52 Bn |
| Dec 31, 2023 | 3.59 Bn |
| Sep 30, 2023 | 3.66 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 2.03 Bn |
| Dec 31, 2022 | 2.06 Bn |
| Sep 30, 2022 | 2.07 Bn |
| Jun 30, 2022 | 2.13 Bn |
| Mar 31, 2022 | 2.20 Bn |
| Dec 31, 2021 | 2.26 Bn |